Chinese Journal of Endocrine Surgery 2019;13(5):353-356

doi:10.3760/cma.j.issn.1674-6090.2019.05.001

To strengthen the treatment of genitourinary syndrome of menopause in breast cancer patients

Lingquan KONG 1 ; Jiashuo LIU ; Hao LI ; Hongyuan LI ; Guosheng REN ; Kainan WU

Affiliations

+expand

Keywords

Breast cancer; Genitourinary syndrome of menopause; Vulvovaginal atrophy; Chemotherapy-induced amenorrhea

Country

China

Language

Chinese

Abstract

Genitourinary syndrome of menopause (GSM),is a common disease in postmenopausal women.It is reported that the incidence of GSM in breast cancer patients (79％-95％) was higher than that in normal counterparts (more than 50％).GSM significantly reduced the quality of life in breast cancer patients,but was not given enough attention,and most of breast cancer patients with GSM were not diagnosed and treated.In addition,chemotherapy and endocrine therapy for breast cancer may increase the incidence and severity of GSM.Hence,prevention and treatment of GSM should be strengthened in breast cancer patients.